AL-Omiri, Mahmoud K.
Alqahtani, Nasser M.
Alahmari, Nasser M.
Hassan, Raed Abul
Al Nazeh, Abdullah A.
Lynch, Edward
Article History
Received: 8 March 2021
Accepted: 12 May 2021
First Online: 27 May 2021
Competing interests
: Edward Lynch has been the main researcher for healOzone grants to Universities from Curozone, and Queen’s University has sold and assigned the rights for healOzone patents in Edward Lynch’s name to Curozone. Edward Lynch does not receive any royalties, and this investigation was not funded (neither by Curozone nor by any other company). The other authors have no conflicts of interests.